MakerBot and Ultimaker Agree to Merge to Accelerate Global Adoption of Additive Manufacturing

MakerBot and Ultimaker, two leaders in desktop 3D printing, today announced that they have come to a business combination agreement that will accelerate the adoption of additive manufacturing by providing a comprehensive desktop 3D printing ecosystem of hardware, software, and materials.

The new entity will be backed by existing investors, NPM Capital and Stratasys (Nasdaq: SSYS), and will benefit from a planned cash investment of $62.4 million to fuel innovation and expansion into new markets. The new company will be led by Nadav Goshen, current MakerBot CEO, and Jürgen von Hollen, current Ultimaker CEO, who will act as Co-CEOs, with Nadav managing operations and R&D and Jürgen managing the commercial functions.“

“This merger marks an important milestone for Ultimaker and MakerBot,” says Jürgen von Hollen, CEO of Ultimaker. “Innovation and growth are both critical to bringing desktop 3D printing from a specialty technology into mainstream business adoption. The new company will leverage and expand its combined global footprint with sales and operations in the Americas, EMEA and APAC.”

“Technological innovation is paramount in growing the availability of easy-to-use professional 3D printing solutions,” says Nadav Goshen, CEO of MakerBot. “By combining our teams and leveraging the additional funding, we can accelerate the development of advanced solutions to provide our customers with a broad portfolio of hardware and software solutions to serve a wide spectrum of customers and applications."

The new entity aims to offer easy-to-use and accessible desktop 3D printing solutions for any application while inspiring the industry to a future state of responsible and sustainable manufacturing. 

The new company will maintain headquarters in both The Netherlands and New York, USA. The transaction is subject to consultation of appropriate employee representative bodies and regulatory approvals, with closing currently expected over the course of the second or third quarters of 2022.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.